Acquisition History / Ono Pharmaceutical Co., Ltd. / Deciphera Pharmaceuticals, Inc.
Ono Pharmaceutical Co., Ltd. Acquires Deciphera Pharmaceuticals, Inc.
Announced April 30, 2024 — $2.40B
What happened
Ono Pharmaceutical agreed to acquire Massachusetts-based Deciphera Pharmaceuticals via a tender offer run through a newly formed US subsidiary. Deciphera develops cancer drugs and had revenue of about JPY 25.5bn with an operating loss. Ono said the deal adds oncology R&D capability and strengthens its commercial base in the US and Europe.
- Acquirer
- Ono Pharmaceutical Co., Ltd.
- Target
- Deciphera Pharmaceuticals, Inc.
- Announced
- April 30, 2024
- Price
- $2.40B
- Industry
- Biopharmaceuticals
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Ono Pharmaceutical Co., Ltd. acquire Deciphera Pharmaceuticals, Inc.?
Ono Pharmaceutical Co., Ltd. acquired Deciphera Pharmaceuticals, Inc. on April 30, 2024. This was Ono Pharmaceutical Co., Ltd.'s 1st publicly tracked acquisition out of 1 we have on record.
How much did Ono Pharmaceutical Co., Ltd. pay for Deciphera Pharmaceuticals, Inc.?
Ono Pharmaceutical Co., Ltd. paid $2.40B for Deciphera Pharmaceuticals, Inc..
What does Deciphera Pharmaceuticals, Inc. do?
Ono Pharmaceutical agreed to acquire Massachusetts-based Deciphera Pharmaceuticals via a tender offer run through a newly formed US subsidiary. Deciphera develops cancer drugs and had revenue of about JPY 25.5bn with an operating loss. Ono said the deal adds oncology R&D capability and strengthens its commercial base in the US and Europe.
What other Biopharmaceuticals companies has Ono Pharmaceutical Co., Ltd. acquired?
Deciphera Pharmaceuticals, Inc. is Ono Pharmaceutical Co., Ltd.'s only publicly tracked acquisition in Biopharmaceuticals so far.
More Biopharmaceuticals acquisitions
Servier acquires Muscular dystrophy business of Edgewise Therapeutics Inc.
$2.65B · 2026
Kotak Special Situations Fund acquires Biocon Biologics Limited
Price not disclosed (CCI combination order) · 2023
ESOF III Investment Fund acquires Biocon Biologics Limited
Price not disclosed (CCI combination order) · 2023